Pure Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2020
December 16, 2020 at 02:35 am IST
Share
PURE Bioscience, Inc. announced earnings results for the first quarter ended October 31, 2020. For the first quarter, the company announced total revenue was USD 1.591 million compared to USD 398,000 a year ago. Operating loss was USD 179,000 compared to USD 1.130 million a year ago. Net loss was USD 180,000 compared to USD 1.125 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.
PURE Bioscience, Inc. is focused on developing and commercializing its proprietary antimicrobial products primarily in the food safety arena. The Company provides solutions to combat the health and environmental problems of pathogen and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The Company offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies. It also offers PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The Company sells its products directly and indirectly through third-party distributors.